<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Subtypes of calcinosis cutis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Subtypes of calcinosis cutis</h1>
<div class="graphic"><div class="figure"><div class="ttl">Subtypes of calcinosis cutis</div><div class="cntnt"><table cellspacing="0"><colgroup width="10%"></colgroup><colgroup span="3" width="30%"></colgroup> <tbody> <tr> <td class="subtitle1">Subtype</td> <td class="subtitle1">Etiology</td> <td class="subtitle1">Common clinical findings</td> <td class="subtitle1">Associated manifestations</td> </tr> <tr> <td class="divider_bottom" rowspan="14"><strong>Dystrophic</strong></td> <td>Systemic sclerosis</td> <td>Firm papules, plaques or nodules usually on the hands, feet, or extremities, often in sites of minor trauma</td> <td> <p>Limited systemic sclerosis (cutaneous sclerosis primarily involving hands and distal forearms), CREST syndrome</p> </td> </tr> <tr> <td>Dermatomyositis</td> <td>Firm papules, plaques or nodules on the extremities (particularly elbows, knees, shoulders, and buttocks), often in sites of repeated trauma; deposits may be intracutaneous, subcutaneous, fascial, or intramuscular</td> <td>Gottron papules, heliotrope eruption, poikiloderma, periungual capillary changes, proximal muscle weakness</td> </tr> <tr> <td>Systemic lupus erythematosus</td> <td>Often an asymptomatic incidental radiologic finding; often buttocks and extremities</td> <td>Manifestations of systemic lupus erythematosus</td> </tr> <tr> <td>Pancreatic enzyme panniculitis</td> <td>Painful subcutaneous nodules, often on pretibial skin with ulceration; may drain an oily substance</td> <td>Manifestations of pancreatic disease, particularly pancreatitis or pancreatic adenocarcinoma</td> </tr> <tr> <td>Subcutaneous fat necrosis of the newborn</td> <td>Erythematous nodules and plaques, especially on cheeks, back, buttocks, and extremities</td> <td>Risk of hypercalcemia</td> </tr> <tr> <td>Lupus panniculitis</td> <td>Firm subcutaneous nodules on the head, proximal extremities, or trunk</td> <td>Systemic lupus erythematosus may or may not be present</td> </tr> <tr> <td>Porphyria cutanea tarda</td> <td>Firm plaques within sites of cutaneous sclerosis that may exhibit ulceration or transepidermal elimination of calcium; usually on head, neck, or dorsal hands</td> <td>Photosensitivity, skin fragility, blistering, sclerodermoid changes</td> </tr> <tr> <td>Pseudoxanthoma elasticum</td> <td>Clinically evident calcification rare; if occurs, may exhibit papules or nodules extruding calcium</td> <td>Yellowish papules in flexural areas, angioid streaks, cardiovascular abnormalities</td> </tr> <tr> <td>Werner syndrome</td> <td>Painful soft tissue calcification with ulceration, usually involving Achilles tendon and knee or elbow tendons</td> <td>Premature aging, scleroderma-like skin changes</td> </tr> <tr> <td>Ehlers-Danlos syndromes</td> <td>Calcified spheroids, focal subcutaneous calcification, calcification within molluscoid pseudotumors</td> <td>Connective tissue abnormalities (eg, skin hyperextensibility, joint hypermobility, tissue fragility)</td> </tr> <tr> <td>Cutaneous neoplasms</td> <td>Most common in pilomatricomas; sometimes only noted histologically</td> <td>N/A</td> </tr> <tr> <td>Trauma</td> <td>Firm, whitish papules or subcutaneous nodules</td> <td>History of injury to involved area; may precede calcification by years</td> </tr> <tr> <td>Onchocerciasis</td> <td>Subcutaneous nodules (onchocercomas) that may calcify over time</td> <td>Ocular changes, pruritus, papular eruptions, hypopigmentation</td> </tr> <tr class="divider_bottom"> <td>Cysticercosis</td> <td>Papulonodules</td> <td>Seizures, headache, nausea, vomiting if neurologic involvement</td> </tr> <tr> <td class="divider_bottom" rowspan="4"><strong>Metastatic</strong></td> <td>Chronic renal failure</td> <td>Firm nodules, particularly at periarticular sites</td> <td>Often normal serum calcium and increased serum phosphate</td> </tr> <tr> <td>Hypervitaminosis D</td> <td>Periarticular calcification</td> <td>Symptoms of hypercalcemia and hypercalciuria (weakness, lethargy, headache, nausea, polyuria)</td> </tr> <tr> <td>Albright hereditary osteodystrophy</td> <td>Symmetric cutaneous ossification</td> <td>Pseudohypoparathyroidism, intellectual disability, obesity</td> </tr> <tr class="divider_bottom"> <td>Malignancy</td> <td>Firm, whitish papules or subcutaneous nodules</td> <td>Signs or symptoms of a bone-destroying malignancy</td> </tr> <tr> <td class="divider_bottom" rowspan="3"><strong>Idiopathic</strong></td> <td>Idiopathic calcification of the scrotum</td> <td>Firm, white subcutaneous nodules on the scrotum</td> <td>N/A</td> </tr> <tr> <td>Subepidermal calcified nodule</td> <td>Solitary hard, white papules usually on the head, neck, or upper extremities; less frequently, multiple nodules occur</td> <td>N/A</td> </tr> <tr class="divider_bottom"> <td>Tumoral calcinosis</td> <td>Large calcium deposits around major joints (eg, hips, shoulders, elbows, knees)</td> <td>Some patients have hyperphosphatemia</td> </tr> <tr class="divider_bottom"> <td><strong>Iatrogenic</strong></td> <td>Iatrogenic</td> <td>Firm papules, nodules, or plaques</td> <td>History of intravenous therapy or other medical procedure</td> </tr> <tr> <td><strong>Calciphylaxis</strong></td> <td>Calciphylaxis</td> <td>Painful retiform purpura, stellate ulcers, particularly in areas with high adiposity (eg, buttocks, thighs)</td> <td>End-stage kidney disease, primary hyperparathyroidism, malignancy, liver disease, connective tissue diseases</td> </tr> </tbody></table></div><div class="graphic_footnotes">CREST: calcinosis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, telangiectasia.</div><div id="graphicVersion">Graphic 101583 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
